企業プロフィール
Galapagos NV 株価・ニュース・カタリスト
- ティッカー:
- GLPG
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Belgium
株価パフォーマンス
27.73 USD (-3.75%)
終値
最終更新: 2026年5月7日
1.83B USD
時価総額
株価変動の要因
Current closing-price context is not available for GLPG.
企業概要
事業概要
Galapagos is a biotechnology company with a long history in immunology and inflammatory disease, and it has also redefined itself around partnership and pipeline strategy. Its story is shaped by platform science, corporate evolution, and a global footprint.
所在地とセクター分類
Galapagos is headquartered in Belgium and listed on NASDAQ. It sits in global specialty biotechnology.
ビジネスモデルの特徴
The company depends on pipeline progress, partnership strategy, and the ability to convert its scientific base into durable value. Investors watch clinical updates, business development, and portfolio direction.
バイオ業界での位置付け
Galapagos occupies a global immunology-biotech niche. The stock is driven by whether the company can keep its innovation engine relevant after strategic shifts.
今後のカタリスト
- Galapagos’s catalysts are oncology and cell-therapy repositioning, plus any update that clarifies how much value remains in the post-reshape platform. The market will care more about strategic direction than about broad pipeline optionality.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。